Table 1.
Correlations between ADGRG1 expression and clinicopathologic characteristics in cervical cancer.
| Characteristic | Cases | ADGRG1 expression | P | |
|---|---|---|---|---|
| Low expression | High expression | |||
| Age | ||||
| ≤50 | 87 (65.91) | 45 (51.72) | 42 (48.28) | 0.3595 |
| >50 | 45 (34.09) | 19 (42.22) | 26 (57.78) | |
| FIGO stage | ||||
| I | 85 (64.39) | 47 (55.29) | 38 (44.71) | 0.0455 |
| II | 47 (35.61) | 17 (36.17) | 30 (63.83) | |
| Histological grade | ||||
| Well/moderate | 52 (39.39) | 21 (40.38) | 31 (59.62) | 0.1558 |
| Poorly | 80 (60.61) | 43 (53.75) | 37 (46.25) | |
| Invasive interstatial depth | ||||
| <1/2 | 32 (24.24) | 22 (68.75) | 10 (31.25) | 0.0140 |
| ≥1/2 | 100 (75.76) | 42 (42.00) | 58 (58.00) | |
| Lymphatic matastasis | ||||
| No | 101 (76.52) | 54 (53.47) | 47 (46.53) | 0.0426 |
| Yes | 31 (23.48) | 10 (32.26) | 21 (67.74) | |